Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 213-367-9 | CAS number: 939-97-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10/08/1990 to 10/09/1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline compliant proprietary study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- A non-standard strain was used in the studybut this is not considered to have affected the validity of the study.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- tert-butylbenzaldehyde
- IUPAC Name:
- tert-butylbenzaldehyde
- Test material form:
- other: liquid
- Details on test material:
- The test material was tert-butylbenzaldehyde, obtained from Givaudan Ltd., with batch number 179024. The test material was a liquid, with a purity of 96.8%.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Fü-albino SPF outbred stock
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- The animals were female, outbred stock, IBM: RORO, Fü-albino SPF rats. They were aged approximately 6 weeks at administration, and weighed 98.4-113.5 g. The rats were randomly selected at delivery, and acclimatised to the laboratory conditions for 7 days. They were housed individually in labelled cages, with ad libitum access to food (maintenance diet GLP 343 for rats) and tap water. The animal room was air conditioned, maintained at a temperature of 20-24°C and relative humidity of 45-65% with a 12 h light/dark cycle. The rats were fasted overnight (approximately 18 hours) prior to dosing, feed was returned to the cages approximately 3 hours after dosing.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: rapeseed oil
- Details on oral exposure:
- The test material was suspended in rapeseed oil (Rüböl, DAB 6) using a magnetic stirrer. Homogeneity of the dosing suspension was maintained during treatment using the magnetic stirrer. The preparation was made prior to dosing. The dose volume was 10 ml/kg bw.
- Doses:
- 200, 500 and 800 mg/kg bw.
- No. of animals per sex per dose:
- 5 females per dose level
- Control animals:
- no
- Details on study design:
- A preliminary study was conducted with 4 male and 4 female rats, to determine the most sensitive sex. The rats were given a single oral dose of 500 mg/kg bw. Two females died, therefore female rats were selected for the main study as females appeared to be the most sensitive sex.
Observations for mortality were made following dosing for 14 days. Clinical signs of toxicity were recorded daily (except on weekends). Body weights were recorded immediately prior to treatment (Day 0), then on Days 3, 7, 10 and 14. All surviving rats were sacrificed and subject to gross examination. - Statistics:
- Not required.
Results and discussion
- Preliminary study:
- Two female rats in the preliminary study died (dose = 500 mg/kg bw) therefore female rats were selected for the main study to represent the most sensitive species.
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 800 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 1/5 rats administered 800 mg/kg bw/d died
- Mortality:
- One rat administered 800 mg/kg bw died about 7 hours after treatment. There were no other deaths.
- Clinical signs:
- The 800 mg/kg bw rat that died showed weak condition, abnormal posture and reduced body temperature prior to death. Clinical signs observed in other animals included diarrhoea, soiled urogenital region and piloerection. Diarrhoea and soiled urogenital region disappeared within 3 days following dosing.
- Body weight:
- Body weight gain was reduced in surviving animals administered 800 mg/kg bw.
- Gross pathology:
- No abnormalities were detected.
- Other findings:
- No other findings were reported.
Any other information on results incl. tables
Clinical signs observed in female rats administered tert-butylbenzaldehye
Clinical sign |
Incidence of findings |
||
200 mg/kg bw |
500 mg/kg bw |
800 mg/kg bw |
|
Diarrhoea |
2/5 |
3/5 |
1/5 |
Soiled urogenital region |
0/5 |
3/5 |
1/5 |
Piloerection |
0/5 |
0/5 |
1/5 |
Death | 0/5 | 0/5 | 1/5 |
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute oral LD50 in female rats is considered to be greater than 800 mg/kg bw/d.
- Executive summary:
The acute oral toxicity of tert-butyl benzaldehyde was investigated in fifteen female Fü-albino SPF rats. A preliminary study was conducted which determined that females were the most sensitive sex due to two deaths observed at 500 mg/kg bw. In the main study, the test material was administered in rapeseed oil to fasted rats by gavage at doses of 200, 500 or 800 mg/kg bw. The rats were observed for signs of toxicity and mortality for 14 days. Body weights changes were recorded, and surviving rats were sacrificed at the end of the observation for gross necropsy. One female rat administered 800 mg/kg bw died approximately 7 days after dosing. There were no other mortalities. Reduced body weight gain was observed in rats given 800 mg/kg bw. Clinical signs of toxicity included diarrhoea, soiled urogenital region and piloerection, seen mainly during the first 3 days. No abnormalities were detected at necropsy. It is concluded that the acute oral LD50 in female rats is greater than 800 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.